成年患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.
作者信息
Martin Jennifer H, Norris Ross, Barras Michael, Roberts Jason, Morris Ray, Doogue Matthew, Jones Graham R D
机构信息
Department of Internal Medicine, Pathology Queensland, Royal Brisbane and Women's Hospital, The University of Queensland, Herston, Queensland, Australia.
出版信息
Clin Biochem Rev. 2010 Feb;31(1):21-4.
Abstract
The Review is a welcome and up-to-date consensus statement on the use of vancomycin. Although many of the points are pertinent to Australasian practice, the clinical context may be subtly different such that different recommendations apply here. It is thus an apt time for clinical, biochemical, pharmacological and pathology staff in Australasia to collaborate and discuss the literature with particular relevance to establishing guidelines for an Australasian context. The new TG (Version 14) will be an interesting update in the antibiotic TDM area and we hope it will be used as a springboard for Australasian clinical research into this area.
摘要
该综述是一份关于万古霉素使用的受欢迎且最新的共识声明。尽管其中许多要点与澳大拉西亚地区的实践相关，但临床背景可能略有不同，因此适用不同的建议。因此，对于澳大拉西亚地区的临床、生化、药理和病理工作人员来说，现在是合作并讨论与制定澳大拉西亚地区指南特别相关的文献的恰当时机。新的TG（第14版）将是抗生素治疗药物监测领域一个有趣的更新，我们希望它将成为澳大拉西亚地区该领域临床研究的跳板。
相似文献
1
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.成年患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Clin Biochem Rev. 2010 Feb;31(1):21-4.
2
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人万古霉素治疗药物监测：美国卫生系统药剂师学会、美国感染病学会和感染病学会药剂师协会共识推荐总结。
Pharmacotherapy. 2009 Nov;29(11):1275-9. doi: 10.1592/phco.29.11.1275.
3
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会修订的共识指南及综述
Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303.
4
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.万古霉素治疗指南：美国传染病学会、美国卫生系统药师协会和传染病药师协会共识推荐摘要
Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877.
5
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.执行摘要：针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会和传染病药师协会的修订共识指南及综述
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057.
6
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
7
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
8
[Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].临床药师对万古霉素最佳给药方案及治疗药物监测的研究：7年数据分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Jul;30(7):640-645. doi: 10.3760/cma.j.issn.2095-4352.2018.07.005.
9
Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges.儿童万古霉素治疗药物监测：新建议，类似挑战。
J Pediatr Pharmacol Ther. 2020;25(6):472-475. doi: 10.5863/1551-6776-25.6.472.
10
Summary of ASHP/IDSA/SIDP vancomycin monitoring recommendations: a focus on osteomyelitis.美国卫生系统药师协会/美国感染病学会/药物治疗学专业学会万古霉素监测建议总结：聚焦骨髓炎
Orthopedics. 2009 Jul;32(7):499. doi: 10.3928/01477447-20090527-18.
引用本文的文献
1
Vancomycin Rx stewardship training for pharmacist.面向药剂师的万古霉素合理用药管理培训
J Pharm Policy Pract. 2025 Jul 10;18(1):2525354. doi: 10.1080/20523211.2025.2525354. eCollection 2025.
2
Enhancing therapeutic strategies and drug development for patients with kidney disease.改善肾病患者的治疗策略与药物研发。
Expert Opin Drug Saf. 2025 Jul 4:1-26. doi: 10.1080/14740338.2025.2525970.
3
Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study.万古霉素治疗患者的治疗药物监测：一项单中心、前瞻性、观察性、真实世界研究。
Eur J Clin Microbiol Infect Dis. 2025 Jun 13. doi: 10.1007/s10096-025-05182-w.
4
A Successful Experience of Individualized Vancomycin Dosing in Critically Ill Patients by Using a Loading Dose and Maintenance Dose.通过负荷剂量和维持剂量对危重症患者进行个体化万古霉素给药的成功经验
Pharmaceuticals (Basel). 2025 May 2;18(5):677. doi: 10.3390/ph18050677.
5
Carboxylate-Terminated Electrode Surfaces Improve the Performance of Electrochemical Aptamer-Based Sensors.羧基封端的电极表面可提高基于电化学适配体的传感器的性能。
ACS Appl Mater Interfaces. 2025 Feb 5;17(5):8706-8714. doi: 10.1021/acsami.4c21790. Epub 2025 Jan 22.
6
Impact of vancomycin therapeutic drug monitoring on mortality in sepsis patients across different age groups: a propensity score-matched retrospective cohort study.万古霉素治疗药物监测对不同年龄组脓毒症患者死亡率的影响：一项倾向评分匹配的回顾性队列研究
Front Med (Lausanne). 2024 Dec 12;11:1498337. doi: 10.3389/fmed.2024.1498337. eCollection 2024.
7
An evaluation of the empirical vancomycin dosing guide in pediatric cardiology.小儿心脏病学中经验性万古霉素剂量指南的评估。
BMC Pediatr. 2024 Sep 11;24(1):575. doi: 10.1186/s12887-024-05048-8.
8
Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability.耐万古霉素金黄色葡萄球菌（VRSA）可以克服抗生素耐药的代价，并且可能威胁到万古霉素的临床持久性。
PLoS Pathog. 2024 Aug 29;20(8):e1012422. doi: 10.1371/journal.ppat.1012422. eCollection 2024 Aug.
9
Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges.生物传感器技术在医疗诊断和治疗药物监测中的创新应用：应用、最新进展和未来研究挑战。
Sensors (Basel). 2024 Aug 8;24(16):5143. doi: 10.3390/s24165143.
10
Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study.头孢洛林酯在复杂性皮肤和软组织感染患者中的真实世界应用及治疗结果：一项多国回顾性研究
Infect Drug Resist. 2024 Jul 4;17:2773-2783. doi: 10.2147/IDR.S455515. eCollection 2024.
本文引用的文献
1
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.旨在实现新目标浓度的万古霉素剂量指南的制定与评估。
J Antimicrob Chemother. 2009 May;63(5):1050-7. doi: 10.1093/jac/dkp085. Epub 2009 Mar 19.
2
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
3
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.门诊胃肠外抗生素治疗中持续输注万古霉素相关肾毒性的危险因素。
J Antimicrob Chemother. 2008 Jul;62(1):168-71. doi: 10.1093/jac/dkn080. Epub 2008 Mar 10.
4
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.更大剂量的万古霉素（至少每天4克）与肾毒性发生率增加有关。
Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6. doi: 10.1128/AAC.01602-07. Epub 2008 Jan 28.
5
Antimicrobial dosing considerations in obese adult patients.肥胖成年患者的抗菌药物剂量考量
Pharmacotherapy. 2007 Aug;27(8):1081-91. doi: 10.1592/phco.27.8.1081.
6
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides.用糖肽类药物治疗耐苯唑西林金黄色葡萄球菌引起的肺炎。
Crit Care Med. 2005 Sep;33(9):1983-7. doi: 10.1097/01.ccm.0000178180.61305.1d.
7
Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.严重葡萄球菌感染中万古霉素持续输注与间歇输注的比较：前瞻性多中心随机研究。
Antimicrob Agents Chemother. 2001 Sep;45(9):2460-7. doi: 10.1128/AAC.45.9.2460-2467.2001.
Zotero 插件